Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
China Journal of Chinese Materia Medica ; (24): 2503-2507, 2015.
Artigo em Inglês | WPRIM | ID: wpr-284784

RESUMO

Allergic reactions caused by traditional Chinese medicine injections (TCMIs) become a greatest concern in the clinic application safety. The integral animal evaluation method commonly used in the preclinical evaluation for allergic reactions of TCMIs was not sensitive, specific, quick and objective in observation indexes. Therefore, more researchers have paid attention to the in vitro test method for evaluating allergic reactions induced by TCMIs. Currently, the methods for evaluating allergic reactions induced by TCMIs are mainly targeted at type I allergic reaction and anaphylactic reaction, with only a few in vitro methods for evaluating type II allergic reaction. In this paper, researchers summarized relevant literatures published about evaluation methods for allergic reactions induced by TCMIs in recent years.


Assuntos
Animais , Humanos , Ativação do Complemento , Hipersensibilidade a Drogas , Diagnóstico , Injeções , Medicina Tradicional Chinesa
2.
Acta Pharmaceutica Sinica ; (12): 1199-1203, 2011.
Artigo em Chinês | WPRIM | ID: wpr-233012

RESUMO

This study is to investigate the effect of compound B2 on the damage of PC12 cells induced by serum deprivation and to explore its related mechanisms. The binding characteristics of B2 to rat striatum adenosine A2A receptor was studied by radioligand 3H-MSX-2 binding assay. Cell viability was detected by MTT assay. ROS formation was measured after DCFDA fluorescent staining. B2 has affinity to rat adenosine A2A receptor (K1 = 0.37 micromol x L(-1)). B2 remarkably increased PC12 cell survival rate in serum deprivation-induced PC12 cells. The percentage of serum deprivation-induced death of PC12 was 49.6%, and the treatment of B2 (0.1-100 micromol x L(-1)) increased the cell viability to 63.3%, 74.9%, 86.3% and 88.1%, respectively. Adenosine A2A receptor antagonist SCH 58261 could significantly block the protective effect of B2. The cell viability with 0.1 micromol x L(-1) SCH 58261 decreased by 16.1%, 24.0% and 19.8%, in the presence of B2 (0.1-10 micromol x L(-1)). Serum deprivation-induced ROS formation was 3.5 times more than that of control group, and treatment with B2 significantly and dose-dependently inhibited ROS over-formation. The protective effect of B2 may be related with adenosine A2A receptor. Decrease of serum-deprivation induced ROS formation may also be one of the mechanisms.


Assuntos
Animais , Feminino , Masculino , Ratos , Adenosina , Metabolismo , Farmacologia , Antagonistas do Receptor A2 de Adenosina , Farmacologia , Sobrevivência Celular , Corpo Estriado , Metabolismo , Meios de Cultura Livres de Soro , Células PC12 , Pirimidinas , Farmacologia , Ratos Wistar , Espécies Reativas de Oxigênio , Metabolismo , Receptor A2A de Adenosina , Metabolismo , Triazóis , Farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA